Skip to main content


OUR VISION

at Life Healthcare Group is to be a market-leading, international, diversified healthcare organisation.

SUMMARY

  • Revenue of
    R25.4 billion

  • Normalised EBITDA* pre-IFRS 16 of
    R4.1 billion

  • Estimated negative impact of COVID-19 on normalised EBITDA
    R2.1 billion

  • Cash generated from operations of
    R4.6 billion



COMMENTARY

OVERVIEW

Life Healthcare's 2020 financial year was a year of vastly different halves. The Group delivered an excellent performance during H1 FY2020 but trading was significantly impacted in H2 FY2020 by the COVID-19 pandemic (the pandemic). The primary focus of the Group in H2 FY2020 was to manage the impact of the pandemic.




Connect with us


© Copyright by Life Healthcare group. All rights reserved.
Previous